Core Insights - Jones Lang LaSalle (JLL) reported a revenue of $7.61 billion for the quarter ended December 2025, reflecting an 11.7% increase year-over-year [1] - The earnings per share (EPS) for the quarter was $8.71, up from $6.15 in the same quarter last year, indicating strong growth [1] - The reported revenue exceeded the Zacks Consensus Estimate of $7.33 billion by 3.78%, and the EPS surpassed the consensus estimate of $7.25 by 20.18% [1] Financial Performance Metrics - JLL's Adjusted EBITDA for Leasing Advisory / Markets Advisory was $225.8 million, exceeding the average estimate of $186.19 million [4] - Adjusted EBITDA for Capital Markets reached $171.2 million, surpassing the average estimate of $145.51 million [4] - The Adjusted EBITDA for Investment Management was $27.7 million, slightly below the average estimate of $29.65 million [4] - In Software & Technology Solutions, Adjusted EBITDA was $1 million, significantly better than the average estimate of -$2.15 million [4] - Adjusted EBITDA for Real Estate Management Services was $162.4 million, slightly above the average estimate of $159.25 million [4] Stock Performance - Over the past month, JLL shares have returned -16.7%, compared to a -1.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Exelon reported a revenue of $5.41 billion for the quarter ended December 2025, reflecting a decrease of 1.1% year-over-year, and an EPS of $0.59, down from $0.64 in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $5.54 billion, resulting in a surprise of -2.27%, while the EPS exceeded the consensus estimate of $0.53 by 11.74% [1] Financial Performance Metrics - Exelon's operating revenues for PECO were $1.17 billion, surpassing the average estimate of $1.03 billion by three analysts, marking a year-over-year increase of 17.4% [4] - Operating revenues for ComEd were reported at $1.09 billion, significantly lower than the estimated $1.85 billion, representing a decline of 39.9% year-over-year [4] - Operating revenues for PHI reached $1.73 billion, exceeding the average estimate of $1.56 billion, with a year-over-year change of 14.5% [4] - Operating revenues for BGE were $1.43 billion, above the average estimate of $1.17 billion, indicating a year-over-year increase of 23.8% [4] Electric and Natural Gas Revenues - Electric revenues for Pepco were reported at $828 million, exceeding the estimated $747.65 million, with a year-over-year increase of 15% [4] - Electric revenues for DPL were $426 million, slightly above the average estimate of $406.12 million, reflecting a year-over-year growth of 10.1% [4] - Electric revenues for ACE were $390 million, surpassing the estimated $379.14 million, with a year-over-year change of 12.1% [4] - Natural gas revenues for PECO were $277 million, exceeding the average estimate of $200.12 million, representing a year-over-year increase of 31.9% [4] - Electric revenues for BGE were $1.06 billion, above the average estimate of $858.86 million, indicating a year-over-year increase of 24.6% [4] - Electric revenues for PECO were $895 million, exceeding the estimated $816.22 million, with a year-over-year change of 13.6% [4] - Natural gas revenues for BGE were $376 million, surpassing the average estimate of $305.16 million, reflecting a year-over-year increase of 21.3% [4] Stock Performance - Exelon's shares have returned +2% over the past month, contrasting with the Zacks S&P 500 composite's -0.3% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Principal Financial (PFG) reported a revenue of $4.46 billion for the quarter ended December 2025, reflecting a year-over-year increase of 9.2% and surpassing the Zacks Consensus Estimate of $4.11 billion by 8.34% [1] - The company's earnings per share (EPS) was $2.19, an increase from $1.94 in the same quarter last year, although it fell short of the consensus estimate of $2.23 by 1.72% [1] Financial Performance Metrics - Assets under management (AUM) for International Pension stood at $153.90 billion, slightly above the average estimate of $153.64 billion [4] - AUM for Investment Management was reported at $593.90 billion, below the average estimate of $611.14 billion [4] - Revenue from fees and other revenues was $1.14 billion, slightly below the average estimate of $1.17 billion, marking a year-over-year increase of 1.9% [4] - Net investment income revenue was $1.2 billion, compared to an average estimate of $1.25 billion, reflecting a year-over-year increase of 7% [4] - Premiums and other considerations revenue reached $2.1 billion, exceeding the average estimate of $1.81 billion, representing a significant year-over-year increase of 15% [4] Segment Performance - In the Principal Asset Management Segment, fees and other revenues were $544.1 million, below the average estimate of $565.87 million, with a year-over-year increase of 1.5% [4] - Net investment income in the Principal Asset Management Segment was $149.7 million, falling short of the average estimate of $180.76 million, showing a year-over-year decline of 8.4% [4] - In the Benefits and Protection Segment, Specialty Benefits fees and other revenues were $7.9 million, below the average estimate of $8.58 million, reflecting a year-over-year decrease of 4.8% [4] - Specialty Benefits premiums and other considerations revenue was $837.9 million, slightly above the average estimate of $835.76 million, with a year-over-year increase of 2.8% [4] - Total revenue for Specialty Benefits in the Benefits and Protection Segment was $898.2 million, exceeding the average estimate of $896.11 million, representing a year-over-year increase of 2.9% [4] - Life Insurance fees and other revenues were reported at $119.9 million, below the average estimate of $124.93 million, with a year-over-year increase of 4.7% [4] Stock Performance - Shares of Principal Financial have returned +7.8% over the past month, contrasting with the Zacks S&P 500 composite's -0.2% change, indicating a relatively strong performance [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - ASGN Inc reported revenue of $980.1 million for the quarter ended December 2025, reflecting a year-over-year decline of 0.5% and an EPS of $1.15, down from $1.28 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $974.76 million by 0.55%, while the EPS fell short of the consensus estimate of $1.18 by 2.54% [1] Revenue Breakdown - Federal Government revenues were $281.5 million, slightly above the estimated $281.31 million, but down 3.7% year-over-year [4] - Commercial revenues totaled $698.6 million, surpassing the estimated $693.46 million, with a year-over-year increase of 0.9% [4] - Commercial Consulting revenues reached $339.4 million, exceeding the average estimate of $335.48 million, marking a significant year-over-year increase of 19.2% [4] - Commercial Assignment revenues were $359.2 million, slightly above the estimated $357.98 million, but represented a year-over-year decline of 12% [4] Stock Performance - ASGN Inc shares have returned +5.2% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.9% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Viewpoint - Booking Holdings (NASDAQ:BKNG) is a major player in the online travel industry, facing competition from companies like Expedia and TripAdvisor. The stock was downgraded by Citigroup from "Outperform" to "Market Perform" with a price of $4,644.64 at the time of the downgrade [1][5]. Stock Performance - BKNG's stock closed at $4,644.64, reflecting a significant decline of 9.32% from the previous day, which is more severe compared to the S&P 500, Dow, and Nasdaq, which saw losses of 0.84%, 0.34%, and 1.43% respectively [2]. - Over the past month, BKNG's stock has decreased by 4.57%, underperforming the Retail-Wholesale sector's gain of 6.19% and the S&P 500's increase of 1.8% [2]. Upcoming Earnings Report - Investors are anticipating BKNG's earnings report scheduled for February 18, 2026, with an expected earnings per share (EPS) of $47.53, representing a 14.39% increase from the same quarter last year [3]. - The Zacks Consensus Estimate projects net sales of $6.11 billion, indicating an 11.69% rise from the previous year, suggesting potential growth despite recent stock performance challenges [3]. Trading Range and Market Capitalization - BKNG's stock has traded between a low of $4,615.19 and a high of $5,115 in the current session, with a yearly high of $5,839.41 and a low of $4,096.23 [4]. - The company's market capitalization is approximately $149.7 billion, with a current trading volume of 625,999 shares on the NASDAQ exchange [4].

Core Insights - ResMed reported $1.42 billion in revenue for the quarter ended December 2025, marking an 11% year-over-year increase and a 2.3% surprise over the Zacks Consensus Estimate of $1.39 billion [1] - The earnings per share (EPS) for the same period was $2.81, compared to $2.43 a year ago, resulting in a 4.59% surprise over the consensus EPS estimate of $2.69 [1] Financial Performance Metrics - U.S., Canada, and Latin America - Devices revenue was $448 million, exceeding the estimated $441.42 million, reflecting an 8.1% year-over-year increase [4] - U.S., Canada, and Latin America - Masks and other revenue reached $387 million, surpassing the average estimate of $367.97 million, with a year-over-year change of 15.7% [4] - Combined Europe, Asia, and other markets - Total revenue was $420.9 million, above the estimated $408.04 million, showing an 11.8% year-over-year increase [4] - Combined Europe, Asia, and other markets - Devices revenue was $278.2 million, slightly above the estimated $275.44 million, with a 9.2% year-over-year change [4] - Combined Europe, Asia, and other markets - Masks and other revenue was $142.7 million, exceeding the average estimate of $132.59 million, reflecting a 17.2% year-over-year increase [4] - U.S., Canada, and Latin America - Total revenue was $835 million, surpassing the estimated $809.39 million, with an 11.5% year-over-year change [4] - Global revenue for Total Sleep and Breathing Health was $1.26 billion, exceeding the estimated $1.2 billion, marking an 11.6% year-over-year increase [4] - Global revenue for Residential Care Software was $166.9 million, slightly below the average estimate of $167.55 million [4] - Global revenue for Total Devices was $726.2 million, exceeding the estimated $716.86 million, with an 8.5% year-over-year change [4] - Global revenue for Total Masks and other was $529.7 million, surpassing the estimated $500.57 million, reflecting a 16.1% year-over-year increase [4] Stock Performance - ResMed shares have returned +7% over the past month, outperforming the Zacks S&P 500 composite's +0.8% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Core Insights - Popular (BPOP) reported revenue of $823.84 million for Q4 2025, marking a year-over-year increase of 9.1% and exceeding the Zacks Consensus Estimate by 1.1% [1] - The earnings per share (EPS) for the same quarter was $3.38, up from $2.51 a year ago, representing an EPS surprise of 11.8% compared to the consensus estimate of $3.02 [1] Financial Performance Metrics - Mortgage banking activities generated $3.62 million, below the average estimate of $4.95 million from two analysts [4] - Net Interest Income was reported at $657.55 million, slightly above the average estimate of $653.47 million from two analysts [4] - Service charges on deposit accounts totaled $38.91 million, exceeding the average estimate of $38.49 million from two analysts [4] - Total non-interest income reached $166.29 million, surpassing the average estimate of $163.38 million from two analysts [4] - Other operating income was $19.35 million, compared to the average estimate of $19 million from two analysts [4] - Other service fees amounted to $106.51 million, exceeding the average estimate of $100.84 million from two analysts [4] Stock Performance - Over the past month, shares of Popular have returned -2.3%, contrasting with a +0.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Viewpoint - Spire Inc. is positioned as a significant entity in the energy sector, particularly in natural gas distribution, facing competition from Atmos Energy and CenterPoint Energy [1] Group 1: Stock Performance - As of the latest update, Spire Inc.'s stock is valued at $83.93, reflecting a slight increase of $0.34 or 0.41% [2] - The stock has shown volatility over the past year, with a high of $91.11 and a low of $68.48 [2] - Morgan Stanley has set a price target of $93 for Spire Inc., indicating an 11.30% potential increase from its price of $83.56 [1] Group 2: Upcoming Events - Spire Inc. is scheduled to host a conference call and webcast on February 3, 2026, to announce its fiscal 2026 first-quarter financial results and earnings guidance [3] - A news statement will be released before the market opens, which will be accessible on the company's investor website [3] - The upcoming earnings call is expected to significantly influence investor sentiment and trading activity [4] Group 3: Market Position - The company has a market capitalization of approximately $4.96 billion, indicating a strong presence in the market [4] - The trading volume of 156,425 shares reflects investor interest and confidence in Spire's growth prospects [4]

Core Viewpoint - Investors are currently rebalancing portfolios and strategizing for the upcoming year, with a focus on underperforming stocks, particularly UnitedHealth Group Inc, which has faced significant challenges in 2025 [1]. Group 1: Company Performance - UnitedHealth Group Inc (NYSE:UNH) is the worst performer on the Dow in 2025, primarily due to controversies following the murder of CEO Brian Thompson and a surprise earnings miss in April, leading to a lowered full-year outlook [2]. - The stock has seen a significant decline, losing more than 35% this year, with its price dropping to $324.13, marking its lowest level since April 2020 [3]. - The stock is on track to close out 2025 with only five monthly wins, indicating a prolonged period of underperformance [3]. Group 2: Market Sentiment and Volatility - Despite the underperformance, short-term options traders are leaning bullish, as indicated by a low Schaeffer's put/call open interest ratio, which ranks higher than only 4% of annual readings [5]. - The Schaeffer's Volatility Index (SVI) for UnitedHealth is at 30%, in the 19th percentile of its annual range, suggesting that near-term option traders are expecting low volatility [6]. - Historically, UnitedHealth has outperformed volatility expectations, as reflected in its Schaeffer's Volatility Scorecard (SVS) of 99 out of 100 [6].

Core Insights - Progressive Corp. is the second-largest personal auto insurer in the U.S. and offers various insurance products including commercial auto, motorcycle, and boat insurance [1] Financial Performance - In November 2025, Progressive reported a robust increase in net premiums written, which surged by 11% to $6.2 billion, while net premiums earned escalated by 14% to $6.9 billion [2] - The company's net income experienced a slight downturn of 5%, amounting to $958 million, with earnings per share available to common shareholders dipping to $1.63 from $1.71 [2] Underwriting Efficiency - There was a substantial decrease in total pretax net realized gains on securities, which plummeted by 82% to $32 million [3] - The combined ratio, a critical indicator of underwriting profitability, worsened by 1.5 points to 87.1, indicating a minor decline in underwriting efficiency [3] Growth Metrics - Progressive reported an expansion in policies across several segments, with personal lines policies growing by 11%, agency auto policies climbing to 10.7 million, and direct auto policies hitting 15.9 million [4] - Growth was also observed in special lines and property policies, increasing by 7% and 4%, respectively, leading to an overall rise in companywide policies in force by 11% to 38.4 million [4] Stock Performance - As of the latest trading session, PGR's stock is trading at $227.28, marking a decrease of approximately 1.95% or $4.53 [5] - The stock has fluctuated between a low of $218.83 and a high of $227.46 during the session, with a market capitalization of approximately $133.26 billion and a trading volume of 4,287,279 shares [5]